Eusa Pharma has announced that Stephen Stamp has been appointed to its board as an independent non-executive director.
Mr Stamp states that he aims to assist Eusa Pharma in maintaining its strong recent growth and drive towards future success.
The director was formerly the chief financial officer of K-V Pharmaceutical Company and has previously occupied board-level roles at healthcare firms such as Shire and Xanodyne.
Rolf Stahel, Eusa Pharma's chairman, stated that Mr Stamp's appointment will be key as the company looks to enter the "next phase" of development.
He said: "Stephen's financial expertise and history of success in our industry will prove an important asset as we transition Eusa into one of the most successful companies in its field."
Earlier this year, the company appointed Iain McGill as president of its European and international divisions, a move which completed the establishment of its executive management team and commercial infrastructure.